This inventor holds 2 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Paul Brenneisen: Innovator in Anthelmintic Compounds
Introduction
Paul Brenneisen is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of anthelmintic compounds. With a total of 2 patents, his work has implications for veterinary medicine and animal health.
Latest Patents
Brenneisen's latest patents include innovative compounds such as 2-Phenoxy, -phenylthio-, and -phenyl-amino-benzoxazoles. These compounds exhibit anthelmintic activity in warm-blooded animals. His patents detail the formula for these compounds, where one of R₂ and R₅ is isothiocyano, while the other can be hydrogen, methyl, methoxy, chlorine, or nitro. Additionally, he has developed an anthelmintic composition and method utilizing isothiocyanobenzazoles.
Career Highlights
Throughout his career, Brenneisen has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical and chemical industries. His work has contributed to advancements in the treatment of parasitic infections in animals.
Collaborations
Brenneisen has collaborated with notable colleagues such as Jean-Jacques Gallay and Thomas Wenger. Their combined expertise has furthered research and development in their respective fields.
Conclusion
Paul Brenneisen's contributions to the field of chemistry, particularly in the development of anthelmintic compounds, highlight his innovative spirit and dedication to improving animal health. His patents reflect a commitment to advancing scientific knowledge and practical applications in veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile